- Home
- FTI vs ZTS Comparison
FTI vs ZTS Comparison
Compare FTI & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTI | ZTS |
|---|---|---|
| Founded | 1884 | 1952 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8B | 29.0B |
| IPO Year | 2016 | 2012 |
Fundamental Metrics
Financial Performance| Metric | FTI | ZTS |
|---|---|---|
| Price | $70.72 | $74.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 17 |
| Target Price | $76.59 | ★ $94.86 |
| AVG Volume (30 Days) | 2.5M | ★ 2.9M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | 0.29% | ★ 2.80% |
| EPS Growth | ★ 20.42 | 10.05 |
| EPS | 1.53 | ★ 3.08 |
| Revenue | ★ $9,932,600,000.00 | $9,467,000,000.00 |
| Revenue This Year | $8.16 | N/A |
| Revenue Next Year | $6.49 | $2.59 |
| P/E Ratio | $45.59 | ★ $24.53 |
| Revenue Growth | ★ 9.35 | 2.28 |
| 52 Week Low | $35.29 | $68.92 |
| 52 Week High | $80.70 | $148.30 |
Technical Indicators
Market Signals| Indicator | FTI | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 58.47 |
| Support Level | $70.35 | $73.93 |
| Resistance Level | $71.97 | $78.20 |
| Average True Range (ATR) | 1.63 | 1.68 |
| MACD | 0.18 | 0.69 |
| Stochastic Oscillator | 64.08 | 84.30 |
Price Performance
Historical ComparisonAbout FTI TechnipFMC plc
TechnipFMC PLC is the key provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies. Geographically it operates in Latin America generating the maximum revenue, then Europe and Central Asia, Africa, North America, Asia Pacific and Middle East.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.